Healthcare Sector — Q3 FY26 Earnings Overview
15 companies reported. 11 bullish, 2 neutral, 2 bearish.
Company Results
| Company | Revenue | YoY | Margin | Sentiment |
|---|---|---|---|---|
| Sunpharma | ₹15,469 Cr | +15.1% | 31.9% | bullish high |
| Cipla | ₹7,074 Cr | 0% | 17.7% | bearish high |
| Apollo Hospitals Enterprise | ₹6,477 Cr | +17% | 15.0% | bullish high |
| Apollo Hospitals Enterprise | ₹6,477 Cr | +17% | 15.0% | bullish high |
| Torrent Pharmaceuticals | ₹3,333 Cr | +18% | 32.9% | bullish high |
| Fortis Healthcare | ₹2,265 Cr | +17.5% | 22.3% | bullish high |
| Entero Healthcare Solutions | ₹1,707 Cr | +26% | 4.0% | bullish high |
| Akums Drugs | ₹1,160 Cr | +14.8% | 12.7% | bullish high |
| Eris Lifesciences | ₹807 Cr | +7.4% | 35.0% | bullish high |
| Ecosmobilityhospitality | ₹206 Cr | +22.48% | 11.3% | neutral medium |
| Blue Jet Healthcare | ₹192 Cr | -40% | 20.0% | neutral medium |
| Lincoln Pharmaceuticals | ₹166 Cr | +13.5% | 14.0% | bullish medium |
| Stanley Lifestyles | ₹104 Cr | -5.4% | 11.9% | bearish medium |
| Chandan Healthcare | ₹65 Cr | +20% | 18.2% | bullish high |
| Anlon Healthcare | ₹36 Cr | +281.45% | 35.0% | bullish high |
Key sector risks this quarter
Receivable days are currently ~290 days, posing cash flow risk. Management targets reduction to 150-160 days by FY27, but execution is uncertain.
Stanley Lifestyles · high50% of stores are under 3 years old and underperforming; if they take longer to mature, margin recovery may be pushed out.
Apollo Hospitals Enterprise · highGurugram hospital delayed by 2-3 months due to environmental clearance issues; startup losses could exceed INR 150 crore if occupancy ramps slower than expected.
Torrent Pharmaceuticals · highThird-party supplier disruption continues with no clear timeline for resolution; alternative supplier may take 3-4 quarters.
Sunpharma · highUS generic sales declined due to additional competition on certain products, and recovery depends on resolving manufacturing compliance issues at several sites.